ScholarLens Back to search
2006•Zhongliu fangzhi yanjiuRequires access

Percutaneous Microwave Coagulation Combined with Transcather Hepatic Arterial Chemoembolization in the Treatment of Primary Liver Cancer with Poor Lipiodol Distribution

Wenbo Shao

Open publisher page 1 citations

Abstract

Objective To investigate the therapeutic effect of percutaneous microwave coagulation combined with transcather hepatic arterial chemoembolization(TACE) in the treatment of primary liver cancer with poor lipiodol distribution.Methods Sixty cases having been treated by TACE were randomly divided into two groups.30 patients (combination group) were treated by percutaneous microwave coagulation therapy after TACE.The other 30 patients (control group) were treated by TACE alone.Results The response rates(CR+PR)in the combination group and control group were 70% and 53.3% respectively.There were no additional severe complications in combination group.Conclusion The treatment of percutaneous microwave coagulation combined with TACE is safe and helpful to increase response rate for primary liver cancer patients with poor lipiodol distribution.

About this research paper

What this paper is about

Objective To investigate the therapeutic effect of percutaneous microwave coagulation combined with transcather hepatic arterial chemoembolization(TACE) in the treatment of primary liver cancer with poor lipiodol distribution.Methods Sixty cases having been treated by TACE were randomly divided into two groups.30 patients (combination group) were treated by percutaneous microwave coagulation therapy after TACE.The other 30 patients (control group) were treated by TACE alone.Results The response rates(CR+PR)in the combination group and control group were 70% and 53.3% respectively.There were no additional severe complications in combination group.Conclusion The treatment of percutaneous microwave coagulation combined with TACE is safe and helpful to increase response rate for primary liver cancer patients with poor lipiodol distribution.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic effect of percutaneous microwave coagulation combined with transcather hepatic arterial chemoembolization(TACE) in the treatment of primary liver cancer with poor lipiodol distribution.Methods Sixty cases having been treated by TACE were randomly divided into two groups.30 patients (combination group) were treated by percutaneous microwave coagulation therapy after TACE.The other 30 patients (control group) were treated by TACE alone.Results The response rates(CR+PR)in the combination group and control group were 70% and 53.3% respectively.There were no additional severe complications in combination group.Conclusion The treatment of percutaneous microwave coagulation combined with TACE is safe and helpful to increase response rate for primary liver cancer patients with poor lipiodol distribution.

Key concepts: Lipiodol, Medicine, Percutaneous, Liver cancer, Gastroenterology, Internal medicine, Therapeutic effect, Coagulation

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Percutaneous Microwave Coagulation Combined with Transcather Hepatic Arterial Chemoembolization in the Treatment of Primary Liver Cancer with Poor Lipiodol Distribution — Research Paper | ScholarLens